Medicare Enrolled
Dr. Viralkumar Bhanderi, M.D.
Medical Oncology · Tallahassee, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bhanderi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bhanderi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bhanderi
Dr. Viralkumar Bhanderi is a medical oncology specialist in Tallahassee, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bhanderi performed 56,066 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Bhanderi received a total of $9,118 from 76 pharmaceutical and/or device companies across 453 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bhanderi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 34% volume in FL
$9,118 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 101928 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗56,066
Medicare services
Top 34% in FL for medical oncology
Not available
Unique patients (not deduplicated)
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
45,390 | $0 | $4 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,810 | $0 | $3 |
| Denosumab injection (Prolia/Xgeva) | 1,620 | $18 | $51 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,428 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,343 | $8 | $9 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
884 | $94 | $339 |
| Anti-nausea injection (Aloxi/palonosetron) | 650 | $1 | $28 |
| Anti-nausea injection (ondansetron/Zofran) | 552 | $0 | $9 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
324 | $96 | $378 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
260 | $10 | $69 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
209 | $11 | $61 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
201 | $6 | $69 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
174 | $22 | $84 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
160 | $46 | $189 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
157 | $56 | $239 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
132 | $1 | $6 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
100 | $25 | $89 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
88 | $21 | $79 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
88 | $1 | $3 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
62 | $49 | $178 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
60 | $130 | $474 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
59 | $5 | $20 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
57 | $3 | $11 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
51 | $2 | $7 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
41 | $10 | $42 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
36 | $27 | $156 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
34 | $2 | $8 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
32 | $122 | $453 |
| New patient office visit, complex (60-74 min) | 21 | $164 | $585 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
19 | $16 | $59 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
12 | $128 | $467 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
12 | $126 | $556 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
82.3% high complexity
10.4% medium
7.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,118
Total received (2018-2024)
Avg $1,303/year across 7 years
Top 47% in FL for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
76
Companies
453
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,595
2023
$1,848
2022
$1,725
2021
$1,062
2020
$310
2019
$1,343
2018
$1,235
Payments by company (2024)
Astellas Pharma US Inc
$432
SEAGEN INC.
$199
Novartis Pharmaceuticals Corporation
$182
SOBI, INC
$107
Ipsen Biopharmaceuticals, Inc
$99
GlaxoSmithKline, LLC.
$98
Celgene Corporation
$56
PFIZER INC.
$45
Pharmacosmos Therapeutics Inc.
$39
Bayer Healthcare Pharmaceuticals Inc.
$37
Genentech USA, Inc.
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Exelixis Inc.
$25
Octapharma USA, Inc.
$25
ABBVIE INC.
$24
Blueprint Medicines Corporation
$24
Daiichi Sankyo Inc.
$23
Kyowa Kirin, Inc.
$23
PUMA BIOTECHNOLOGY, INC.
$17
Janssen Biotech, Inc.
$17
ARRAY BIOPHARMA INC
$16
Alexion Pharmaceuticals, Inc.
$16
E.R. Squibb & Sons, L.L.C.
$15
Sirtex Medical Inc
$7
Rigel Pharmaceuticals, Inc.
$6
Top 3 companies account for 51.0% of 2024 payments
All-time payments by company (2018-2024) ›
Celgene Corporation
$838
Astellas Pharma US Inc
$771
Novartis Pharmaceuticals Corporation
$656
Genentech USA, Inc.
$509
Boehringer Ingelheim International GmbH
$485
PFIZER INC.
$460
Amgen Inc.
$408
AstraZeneca Pharmaceuticals LP
$340
Janssen Biotech, Inc.
$318
Merck Sharp & Dohme LLC
$254
Ipsen Biopharmaceuticals, Inc
$239
E.R. Squibb & Sons, L.L.C.
$208
Foundation Medicine, Inc.
$200
SEAGEN INC.
$199
GlaxoSmithKline, LLC.
$181
Merck Sharp & Dohme Corporation
$175
Daiichi Sankyo Inc.
$161
Takeda Pharmaceuticals U.S.A., Inc.
$147
SOBI, INC
$127
Pharmacyclics LLC, An AbbVie Company
$117
Incyte Corporation
$115
Octapharma USA, Inc.
$104
BOSTON SCIENTIFIC CORPORATION
$103
GENZYME CORPORATION
$96
ARRAY BIOPHARMA INC
$89
Pharmacosmos Therapeutics Inc.
$88
AMAG Pharmaceuticals, Inc.
$84
Exelixis Inc.
$78
Clovis Oncology, Inc.
$75
AbbVie Inc.
$70
Boehringer Ingelheim Pharmaceuticals, Inc.
$68
Kite Pharma, Inc.
$67
Heron Therapeutics, Inc.
$61
ABBVIE INC.
$59
Secura Bio, Inc.
$53
Blueprint Medicines Corporation
$53
Kyowa Kirin, Inc.
$49
Sysmex Inostics Inc
$45
Regeneron Healthcare Solutions, Inc.
$44
Janssen Pharmaceuticals, Inc
$43
PUMA BIOTECHNOLOGY, INC.
$42
Emmaus Medical, Inc.
$40
Coherus Biosciences Inc.
$39
Pharmacyclics LLC, an AbbVie Company
$39
Lexicon Pharmaceuticals, Inc.
$38
MorphoSys, US Inc.
$38
Lilly USA, LLC
$38
Bayer Healthcare Pharmaceuticals Inc.
$37
Eisai Inc.
$36
Partner Therapeutics, Inc.
$35
CSL Behring
$34
Bayer HealthCare Pharmaceuticals Inc.
$33
Karyopharm Therapeutics Inc.
$32
EMD Serono, Inc.
$28
GE HealthCare
$28
Rigel Pharmaceuticals, Inc.
$22
Array BioPharma Inc.
$22
JAZZ PHARMACEUTICALS INC.
$21
AbbVie, Inc.
$21
G1 Therapeutics, Inc.
$20
BeiGene USA, Inc.
$20
Janssen Scientific Affairs, LLC
$19
CTI BioPharma Corp.
$18
SECURA BIO, INC.
$18
SANOFI-AVENTIS U.S. LLC
$18
Alexion Pharmaceuticals, Inc.
$16
INSYS Therapeutics Inc
$15
Aveo Pharmaceuticals, Inc.
$15
Mirati Therapeutics, Inc.
$14
Apellis Pharmaceuticals, Inc.
$14
Global Blood Therapeutics, Inc.
$14
Seagen Inc.
$14
TG Therapeutics, Inc.
$12
Gilead Sciences, Inc.
$12
NanoString Technologies, Inc.
$11
Sirtex Medical Inc
$7
Top 3 companies account for 24.9% of all-time payments
Associated products mentioned in payments ›
AYVAKIT · Afstyla · Alecensa · Aliqopa · Avastin · BAVENCIO · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · Braftovi · CABLIVI · CABOMETYX · CHANTIX · CINVANTI · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Cinvanti · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · ENHERTU · ERLEADA · EVENITY · Endari · Enhertu · Erleada · FARESTON · FARYDAK · FERAHEME · FOTIVDA · FOUNDATIONONE · Fabhalta · Farydak · GAVRETO · GAZYVA · GILOTRIF · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · IMJUDO · INJECTAFER · INLYTA · Idelvion · Imbruvica · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Leukine · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROSIGNA ASSAY · Padcev · Phesgo · Polivy · Pomalyst · Poteligeo · Prolia · REBLOZYL · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN LAR · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · SYNDROS · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · THERASPHERE · Tavalisse · Tecentriq · UKONIQ · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VONJO · Venclexta · Vitrakvi · Vonjo · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · ZEJULA · ZEPZELCA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
5
County median income
$65,074
Nearest hospital to ZIP centroid (approximate)
TALLAHASSEE MEMORIAL HEALTHCARE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bhanderi is a mixed practice specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bhanderi experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Bhanderi performed 45,390 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Bhanderi receive payments from pharmaceutical companies?
Yes. Dr. Bhanderi received a total of $9,118 from 76 companies across 453 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bhanderi's costs compare to other medical oncologists in Tallahassee?
Dr. Bhanderi's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bhanderi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Tallahassee
Browse medical oncologists in Tallahassee ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology